SCHEMBL28229181

SCHEMBL28229181

CN(C)[C@H](C(=O)O)c1cccc(CN)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.44
OPRK1 P41145 2/20 0.44
OPRM1 P35372 1/20 0.44
LOXL2 Q9Y4K0 2/20 0.43
ENPP2 Q13822 1/20 0.41
ADRA1D P25100 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
ADAMTS4 O75173 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
AOC3 Q16853 1/20 0.38
NOS1 P29475 3/20 0.38
NOS2 P35228 3/20 0.38
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
CYP3A4 P08684 1/20 0.37
NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28229182 1.00 CYP2D6 (0.44) CYP2D6OPRK1OPRM1LOXL2ENPP2
SCHEMBL28229240 0.83 KDM4E (0.42) CYP2D6OPRK1LOXL2CYP2C9TSHR
SCHEMBL28229241 0.83 KDM4E (0.42) CYP2D6OPRK1LOXL2CYP2C9TSHR
SCHEMBL27640013 0.79 PTGS2 (0.54) LOXL2ENPP2ADRA1DCYP2C9TSHR
SCHEMBL28229032 0.78 SRC (0.52) CYP2D6OPRK1OPRM1LOXL2ENPP2
Hydrochloric Acid SCHEMBL4143443 0.78 PTGS2 (0.53) LOXL2ENPP2ADRA1DCYP2C9TSHR
SCHEMBL18946106 0.77 ACP3 (0.47) OPRM1AOC3ALDH1A1GAASMN1; SMN2
SCHEMBL847191 0.77 ACP3 (0.47) OPRM1AOC3ALDH1A1GAASMN1; SMN2
SCHEMBL18920447 0.77 ACP3 (0.47) OPRM1AOC3ALDH1A1GAASMN1; SMN2
SCHEMBL1666938 0.76 AKR1C3 (0.47) LOXL2ENPP2NOS1NOS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108349965-A 1,3,4- thiadiazole compounds and its purposes in treating cancer 阿斯利康(瑞典)有限公司 2018-07-31 CN disclosed